Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-326092
Filing Date
2026-07-30
Accepted
2026-07-30 16:04:13
Documents
121
Period of Report
2026-05-31

Document Format Files

Seq Description Document Type Size
1 10-K neog-20260531.htm   iXBRL 10-K 4277420
2 EX-4.3 neog-ex4_3.htm EX-4.3 17737
3 EX-10.16 neog-ex10_16.htm EX-10.16 31345
4 EX-10.17 neog-ex10_17.htm EX-10.17 23741
5 EX-10.18 neog-ex10_25.htm EX-10.25 26694
6 EX-10.30 neog-ex10_30.htm EX-10.30 106541
7 EX-19 neog-ex19.htm EX-19 58129
8 EX-21 neog-ex21.htm EX-21 45481
9 EX-23 neog-ex23.htm EX-23 4707
10 EX-24 neog-ex24.htm EX-24 54173
11 EX-31.1 neog-ex31_1.htm EX-31.1 16265
12 EX-31.2 neog-ex31_2.htm EX-31.2 16510
13 EX-32 neog-ex32.htm EX-32 12066
14 EX-97 neog-ex97.htm EX-97 25188
15 GRAPHIC img126197151_0.jpg GRAPHIC 27580
16 GRAPHIC img184510934_0.jpg GRAPHIC 646845
17 GRAPHIC img184510934_1.jpg GRAPHIC 110067
  Complete submission text file 0001193125-26-326092.txt   22650178

Data Files

Seq Description Document Type Size
18 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20260531.xsd EX-101.SCH 2804345
125 EXTRACTED XBRL INSTANCE DOCUMENT neog-20260531_htm.xml XML 4618363
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-K | Act: 34 | File No.: 000-17988 | Film No.: 261223229
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)